INTS
INTENSITY THERAPEUTICS, INC.

2,330
Mkt Cap
$15.15M
Volume
48,434.00
52W High
$54.50
52W Low
$4.63
PE Ratio
-0.38
INTS Fundamentals
Price
$5.98
Prev Close
$6.33
Open
$6.28
50D MA
$8.32
Beta
0.00
Avg. Volume
88,259.24
EPS (Annual)
-$29.24
P/B
1.63
Rev/Employee
$0.00
$22.02
Loading...
Loading...

About

Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
16

Frequently Asked Questions

What is Market Cap of Intensity Therapeutics Inc?
What is the 52-week high for Intensity Therapeutics Inc?
What is the 52-week low for Intensity Therapeutics Inc?
What is Intensity Therapeutics Inc stock price today?
What was Intensity Therapeutics Inc stock price yesterday?
What is the PE ratio of Intensity Therapeutics Inc?
What is the Price-to-Book ratio of Intensity Therapeutics Inc?
What is the 50-day moving average of Intensity Therapeutics Inc?
How many employees does Intensity Therapeutics Inc have?

Latest INTS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.